Can you take Gaviscon after gastric sleeve surgery? This is a common question among patients managing acid reflux following sleeve gastrectomy. Gastric sleeve surgery significantly alters stomach anatomy, and gastro-oesophageal reflux disease (GORD) is one of the most frequently reported post-operative concerns. Understanding which remedies are safe, effective, and appropriate is essential for recovery. This article explains how Gaviscon works, what UK bariatric guidelines advise about antacids post-surgery, other medicines used for reflux after sleeve gastrectomy, and when to seek advice from your bariatric team or GP.

Acid Reflux After Gastric Sleeve Surgery

Acid reflux affects a significant minority of patients after sleeve gastrectomy, with rates of 20% or higher commonly reported, driven by increased intragastric pressure and anatomical changes including removal of the gastric fundus.

Gastric sleeve surgery, formally known as sleeve gastrectomy, involves removing approximately 75–80% of the stomach to create a narrow, tubular stomach. While this procedure is highly effective for weight loss, it is associated with a notable increase in gastro-oesophageal reflux disease (GORD) in a significant proportion of patients. Studies and systematic reviews suggest that new or worsened reflux symptoms affect a substantial minority of individuals following sleeve gastrectomy — estimates vary widely across the literature, but figures of 20% or higher are commonly reported, making it one of the most frequently cited post-operative concerns.

The anatomical changes caused by the surgery help explain why reflux becomes more prevalent. The reduced stomach size increases intragastric pressure, and the removal of the gastric fundus — which normally acts as a reservoir — means that stomach contents may be more readily pushed upwards into the oesophagus. Additional contributing factors include disruption of the angle of His, the presence of a pre-existing or post-operative hiatal hernia, the shape and compliance of the sleeve, and, in some cases, bile reflux. The effect on the lower oesophageal sphincter is less consistently demonstrated and remains an area of ongoing research.

Symptoms of post-sleeve reflux can include:

• Heartburn — a burning sensation in the chest or throat

• Regurgitation of food or acidic fluid

• Bloating or a feeling of fullness shortly after eating

• Persistent cough or hoarseness, which may indicate silent reflux

It is important to distinguish between mild, occasional reflux and persistent or severe symptoms. Untreated chronic reflux after sleeve gastrectomy can, over time, lead to oesophagitis, Barrett's oesophagus, or other complications. For this reason, managing reflux effectively — and with appropriate medicines — is an important part of post-operative care. The NHS GORD page and NICE guidance (CG184) provide further patient-facing information on symptoms and when to seek help.

How Gaviscon Works and Its Available Formulations

Gaviscon forms an alginate gel raft that floats on stomach contents to physically block acid reflux; Gaviscon Advance liquid is preferred post-bariatric surgery due to its higher alginate concentration and lower sodium content.

Gaviscon is a widely used, over-the-counter remedy for heartburn and acid reflux. It is available in the UK in several formulations, including Gaviscon Original, Gaviscon Advance, and Gaviscon Double Action, each with slightly different compositions and mechanisms. Understanding how Gaviscon works is helpful when considering whether it is appropriate after gastric sleeve surgery.

Gaviscon works primarily as an alginate-based preparation. When swallowed, the sodium alginate (or potassium alginate in Gaviscon Advance) reacts with stomach acid to form a thick, gel-like raft that floats on top of the stomach contents. This raft acts as a physical barrier, helping to prevent acid from refluxing back into the oesophagus. Gaviscon Original and Double Action also contain calcium carbonate and sodium bicarbonate, which provide additional acid-neutralising effects. Gaviscon Advance (available as liquid or chewable tablets) contains a higher concentration of alginate and potassium bicarbonate, but does not contain calcium carbonate; it also has a lower sodium content than Gaviscon Original, which may be relevant for patients on sodium-restricted diets.

For post-bariatric patients, the following points are clinically relevant:

• Gaviscon Advance liquid is often preferred, as it contains a higher alginate concentration, has lower sodium content, and does not require tablet breakdown in a significantly smaller stomach.

• Liquid formulations are generally better tolerated in the early post-operative period.

• Gaviscon does not suppress acid production — it provides a temporary physical barrier only, meaning it may offer symptomatic relief but will not address underlying acid hypersecretion.

• Typical adult dosing (per UK Summary of Product Characteristics): Gaviscon Advance Liquid 5–10 ml after meals and at bedtime; always follow the specific product directions and confirm doses with your pharmacist.

• Gaviscon should be taken after meals and at bedtime to maximise the raft-forming effect.

• Separation from other oral medicines: Gaviscon and other antacid/alginate preparations can affect the absorption of some medicines. As a general precaution, separate Gaviscon from other oral medicines by approximately 2 hours, or follow your pharmacist's advice.

• Sodium and potassium content: Patients with renal impairment, heart failure, or those on potassium- or sodium-restricted diets should seek advice from their GP or pharmacist before use, as different formulations vary in their electrolyte content. Refer to the relevant UK Summary of Product Characteristics (available at emc.medicines.org.uk) for full excipient and caution details.

In general, Gaviscon is considered safe to take after gastric sleeve surgery, and there is no official contraindication to its use in this context. Patients should always confirm suitability with their bariatric team or pharmacist, particularly in the early post-operative period.

What UK Bariatric Guidelines Say About Antacids Post-Surgery

UK guidelines do not prohibit Gaviscon after sleeve gastrectomy; liquid formulations are preferred post-operatively, and Gaviscon should be used as a symptomatic aid alongside — not instead of — prescribed medications such as PPIs.

In the UK, post-bariatric care is guided by recommendations from organisations including NICE (National Institute for Health and Care Excellence), the British Obesity and Metabolic Surgery Society (BOMSS), and individual NHS bariatric centres. While specific guidance on Gaviscon use is not always explicitly detailed, broader recommendations around reflux management after sleeve gastrectomy are well established.

NICE guidance on obesity (CG189 and its updates) and BOMSS post-operative care pathways both acknowledge that GORD is a recognised complication of sleeve gastrectomy. NICE CG184 (Gastro-oesophageal reflux disease and dyspepsia in adults) provides principles for pharmacological management of reflux applicable in this context. Most UK bariatric programmes routinely prescribe proton pump inhibitors (PPIs) — such as omeprazole or lansoprazole — for a period following surgery to protect the gastric mucosa and reduce acid-related symptoms during the healing phase. The duration of PPI prophylaxis varies between centres and is not uniformly mandated by national guidance; your bariatric team will advise on the appropriate duration for your situation.

With regard to antacid and alginate preparations like Gaviscon, UK guidelines do not prohibit their use post-sleeve. However, several practical considerations apply:

• Liquid Gaviscon is preferable in the early post-operative period; tablet formulations should be used with caution.

• Gaviscon should be taken after meals and at bedtime to maximise the raft-forming effect.

• It should be viewed as a symptomatic aid rather than a standalone treatment for significant reflux.

• Patients should not use Gaviscon as a substitute for prescribed medications without first consulting their bariatric team.

• Timing: PPIs are generally most effective when taken 30–60 minutes before food; alginates such as Gaviscon are taken after meals and at bedtime. Separate Gaviscon from other oral medicines by approximately 2 hours.

Some NHS bariatric units include Gaviscon Advance in their recommended post-operative medication lists for managing breakthrough reflux symptoms. BOMSS guidance on medications after bariatric surgery provides further detail on formulation choices (liquid or orodispersible preparations are preferred) and post-operative medication considerations. If you are unsure whether Gaviscon is appropriate for your specific situation, your bariatric nurse specialist or GP can provide personalised guidance.

Other Medicines Commonly Used for Reflux After Sleeve Gastrectomy

PPIs such as omeprazole and lansoprazole are the first-line pharmacological treatment for post-sleeve reflux; prokinetic agents like domperidone and metoclopramide are MHRA-restricted and not indicated for routine reflux management.

Beyond Gaviscon, several other medicines are commonly used to manage reflux following sleeve gastrectomy. Understanding the options available can help patients have more informed conversations with their healthcare team.

Proton pump inhibitors (PPIs) are the most frequently prescribed class of medication for post-bariatric reflux. Medicines such as omeprazole, lansoprazole, and esomeprazole work by blocking the hydrogen-potassium ATPase enzyme in the stomach lining, thereby significantly reducing acid production. PPIs are considered the first-line pharmacological treatment for GORD after sleeve gastrectomy (NICE CG184). They are available on NHS prescription and, in some cases, over the counter. Liquid or dispersible formulations are recommended in the early post-operative period to ensure adequate absorption.

H2 receptor antagonists, such as famotidine, offer a milder degree of acid suppression by blocking histamine receptors in the stomach wall. Low-dose famotidine is available over the counter in the UK, though availability and specific branded products may vary; seek pharmacist advice on current UK options. H2 receptor antagonists may be used when PPIs are not tolerated or as an adjunct therapy.

Prokinetic agents such as domperidone and metoclopramide are occasionally considered in specialist settings to improve gastric emptying, but their use is subject to important MHRA restrictions and should only be initiated by a specialist following careful risk–benefit assessment:

• Domperidone is restricted by the MHRA to the short-term relief of nausea and vomiting only. It is contraindicated in patients with certain cardiac conditions (including prolonged QT interval) and interacts with QT-prolonging medicines. It is not indicated for reflux and should not be used for this purpose without specialist direction. (See MHRA Drug Safety Update on domperidone.)

• Metoclopramide is similarly restricted by the MHRA to short-term use (up to 5 days) for nausea and vomiting only, due to risks of neurological side effects. It is not a routine reflux treatment and should only be used under specialist supervision. (See MHRA Drug Safety Update on metoclopramide.)

It is worth noting that:

• Long-term PPI use carries its own considerations, including potential effects on magnesium levels, vitamin B12 absorption, and bone density — all of which are already monitored as part of routine post-bariatric nutritional follow-up.

• Medicines should never be crushed or split without pharmacist advice, as this can affect their release mechanism and efficacy.

• Gaviscon can be used alongside PPIs as a complementary measure for breakthrough symptoms, but this combination should ideally be discussed with a clinician.

If you experience a suspected side effect from any medicine, you can report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

When to Seek Advice From Your Bariatric Team or GP

Seek prompt medical advice if reflux is persistent, worsening, or accompanied by dysphagia, vomiting, black stools, or chest pain; call 999 or attend A&E immediately for severe symptoms.

Whilst mild, occasional reflux after gastric sleeve surgery can often be managed with lifestyle adjustments and over-the-counter remedies such as Gaviscon, there are important situations where professional medical advice should be sought promptly.

Contact your bariatric team or GP if you experience:

• Reflux symptoms that are persistent, worsening, or not responding to Gaviscon or prescribed medication

• Difficulty swallowing (dysphagia) or pain on swallowing (odynophagia)

• Unintentional weight loss beyond expected post-operative loss

• Vomiting, particularly if it is frequent or contains blood

• Black or tarry stools, which may indicate gastrointestinal bleeding

• Chest pain — always seek urgent assessment to rule out cardiac causes

• Symptoms of severe or new-onset reflux that develop months or years after surgery

Seek emergency help immediately: call 999 or go to your nearest A&E if you have severe chest pain, are vomiting blood, or have signs of significant gastrointestinal bleeding. Call NHS 111 for urgent non-emergency advice if you are unsure.

Persistent, uncontrolled reflux after sleeve gastrectomy may warrant further investigation, including upper GI endoscopy to assess the oesophagus and tubular sleeve stomach, or pH monitoring to quantify acid exposure. Assessment for contributing factors such as hiatal hernia, sleeve stenosis or twist, and bile reflux should also be considered where symptoms are refractory or atypical. In some cases where reflux is severe and refractory to medical management, conversion to Roux-en-Y gastric bypass may be considered, as this procedure is associated with significantly lower rates of GORD.

It is also advisable to review your full medication list with your pharmacist or GP before starting any new over-the-counter remedy, including Gaviscon, to check for potential interactions with your existing post-bariatric medicines or supplements. Your bariatric nurse specialist remains a valuable first point of contact for any concerns related to your post-operative recovery and ongoing symptom management.

In summary, Gaviscon is generally considered safe and may provide useful symptomatic relief after gastric sleeve surgery, but it works best as part of a broader, clinician-guided approach to reflux management.

Frequently Asked Questions